证据进入实践的桥梁

实施科学

Implementation Science
聚焦证据向实践转化，涵盖实施过程、影响因素、实施策略、实施结局与持续改进等核心内容。
⚗️

中医指南实施策略推荐清单（ERIC-TCMG）

围绕中医药临床实践指南实施过程中的策略识别、筛选与应用，提供结构化工具入口。

进入 ERIC-TCMG
📄

研究领域

围绕实施科学的理论框架、影响因素、实施策略、实施评价与应用转化等领域开展相关研究。

理论、模型与框架
影响因素与情境分析
实施策略与应用支持
实施评价与持续改进
✉️

联系我们

欢迎围绕研究合作、工具使用与学术交流进行联系。

相关研究

[1] Li H, Wang Y, Chen Y, Wang X, Lu C, Deng J. The instrument for measuring the implementation situation of traditional Chinese medicine guideline: evaluation and application. Evid Based Complement Alternat Med. 2017;2017:2861924. doi:10.1155/2017/2861924
https://doi.org/10.1155/2017/2861924
[2] Li H, Xie R, Wang Y, Xie X, Deng J, Lu C. A new scale for the evaluation of clinical practice guidelines applicability: development and appraisal. Implement Sci. 2018;13(1):61. doi:10.1186/s13012-018-0746-5
https://doi.org/10.1186/s13012-018-0746-5
[3] Chen W, Xu D, Li H, et al. Theories, models and frameworks of implementation science. Chinese Journal of Evidence-Based Medicine. 2020;20(8):986-992. doi:10.7507/1672-2531.202003238
https://doi.org/10.7507/1672-2531.202003238
[4] Xie R, Xu D, Li H, et al. Research methods for implementation science in health care. Chinese Journal of Evidence-Based Medicine. 2020;20(9):1104-1110. doi:10.7507/1672-2531.202003234
https://doi.org/10.7507/1672-2531.202003234
[5] Xie R, Xia Y, Chen Y, et al. The RIGHT Extension Statement for Traditional Chinese Medicine: development, recommendations, and explanation. Pharmacol Res. 2020;160:105178. doi:10.1016/j.phrs.2020.105178
https://doi.org/10.1016/j.phrs.2020.105178
[6] Huang J, Guo W, Li H, Xie R, Shen M, Wang H. Development and validation of a patient-reported outcome scale for tension-type headache. Front Neurol. 2021;12:693553. doi:10.3389/fneur.2021.693553
https://doi.org/10.3389/fneur.2021.693553
[7] Xie X, Wang Y, Li H. AGREE II for TCM: tailored to evaluate methodological quality of TCM clinical practice guidelines. Front Pharmacol. 2023;13:1057920. doi:10.3389/fphar.2022.1057920
https://doi.org/10.3389/fphar.2022.1057920
[8] Li S, Zhang L, Wang Y, et al. Development and validation a methodology model for traditional Chinese medicine good practice recommendation: an exploratory sequential mixed methods study. Front Pharmacol. 2025;16:1501634. doi:10.3389/fphar.2025.1501634
https://doi.org/10.3389/fphar.2025.1501634
[9] Wang Y, Zhang L, Sharifan A, et al. Mixed methods research in the field of clinical practice guidelines: the case of developing a methodological model for Good Practice Recommendation. J Mix Methods Res. 2025;20:160-183. doi:10.1177/15586898251362907
https://doi.org/10.1177/15586898251362907
[10] Xie R, Li H, Fu H, Xia P, Ouyang B, Shi H. Innovation in internet plus pharmaceutical services model in the health 4.0 context: evidence from a repeated cross-sectional study. Technol Forecast Soc Change. 2025;210:123881. doi:10.1016/j.techfore.2024.123881
https://doi.org/10.1016/j.techfore.2024.123881
[11] Li S, Lai WH, Ruan T, Deng Y, Li H, Xie R. Development and prioritization of ERIC-informed implementation strategies for traditional Chinese medicine guidelines: a two-phase mixed methods study. Crit Public Health. 2026;36(1). doi:10.1080/09581596.2026.2681251
https://doi.org/10.1080/09581596.2026.2681251